Verici Dx plc announced it has completed successful transfer of a portion of the Company's urine samples as announced as part of the global commercialisation and licensing agreement announced in November 2023. A s previously stated, it demonstrates the additional value in the Company's data and sample assets for research. Following completion of the transfer, full payment has been received.